Who is sponsoring NCT04584606?

NCT04584606 is sponsored by Ain Shams University.

What drugs are being tested in NCT04584606?

Interventions in NCT04584606: Lab workup (on admission and regularly during follow up)..

What condition does NCT04584606 study?

NCT04584606 studies Coronavirus Disease (COVID-19).

Is NCT04584606 still recruiting?

NCT04584606 is currently status unknown. Last updated 14 October 2020.

Last reviewed 2020-10-14 · How we verify

NCT04584606

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Ain Shams University Experience: Clinical Determinants of Hospitalized COVID-19 Patients

Status unknown Last updated 14 October 2020

What this trial tests

trial testing Lab workup (on admission and regularly during follow up). in Coronavirus Disease (COVID-19) in 100 participants. Status unknown.

Timeline

27 June 2020

Primary endpoint
31 October 2020

30 December 2020

Quick facts

Lead sponsor	Ain Shams University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	100
Start date	27 June 2020
Primary completion	31 October 2020
Estimated completion	30 December 2020
Sites	1 location across Egypt

Drugs / interventions tested

Lab workup (on admission and regularly during follow up).

Conditions studied

Coronavirus Disease (COVID-19) — all drugs for Coronavirus Disease (COVID-19) →

Sponsor

Ain Shams University

Who can join

18 and older, any sex, with Coronavirus Disease (COVID-19). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

COVID-19 as a novel disease, different disease patterns were observed worldwide, and many treatment plans were tried. So, it is important to investigate the Egyptian clinical characteristics and different factors that determine the patient's 'outcome

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Coronavirus Disease (COVID-19)

Currently open trials in the same condition.

NCT06667700 — A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are Hi · Phase 3 · recruiting

Other Ain Shams University trials

Trials by the same sponsor.

NCT07435493 — Fentanyl Versus Opioid Free Multimodal Analgesia for Perioperative Pain Control in Children With Mild to Moderate Obstru · NA · not yet recruiting
NCT07482540 — Role of Dexmedatomidine Drug in Prevention of Atrial Fibrillations Post Mitral Valve Surgery · NA · not yet recruiting
NCT07531030 — Posterior Pericapsular Deep Gluteal Block Combined With Pericapsular Nerve Group and Lateral Femoral Cutaneous Nerve Blo · NA · not yet recruiting
NCT06839027 — Arterial to Central co2gap in Relation to Outcome After Cardiopulmonary Bypass · not yet recruiting
NCT07516535 — DISS vs FANS in Suction-Assisted RIRS for Medium-Sized Renal Stones · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04584606 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ain Shams University
Last refreshed: 14 October 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04584606.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing